Biomarker Development to Improve Trials for Type 1 Diabetes
Professor Matthias von Herrath, The La Jolla Institute for Allergy and Immunology, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Selection and Molecular Profiling of Circulating Tumor Cell (CTC) Sub-populations: Single-Cell Studies of Epithelial-to-Mesenchymal Transitions
Professor Steven Soper, University of North Carolina, speaking at Single Cell Analysis Summit 2013.
Your body is 3D, why is your cell culture not?
Christian Oberdanner, PhD, Application Specialist Sales & Marketing, Tecan Austria GmbH
Circulating Tumor Antigens and their Autoantibody Reactivity as Cancer Markers
Samir Hanash, Program Head, Fred Hutchinson Cancer Research Center, speaking at CellTech 2013.
A lesson for cell-signaling studies using advanced detection techniques
Thomas Hengstl MSc, Application Specialist Marketing, Tecan Austria
Helping you to shape in vitro models with cell-based assays
Christian Oberdanner, Ph.D. Marketing Application Specialist Detection for Tecan Austria
Regulation of antibody immunotherapy by fine-tuning FcR interactions
Mark Cragg, Southampton University School of Medicine, speaking at Stem Cells & Bioprocessing 2012.
Immunogenicity Assessment for the Successful Development of Biosimilars
Dr Michael Tovey, Institut Andre Lwoff/INSERM, speaking at Stem Cells & Bioprocessing 2012.
Bicyclic Peptides with Antibody-Like Binding Affinity and Specificity
Dr Vanessa Baeriswyl, EPFL, speaking at Stem Cells & Bioprocessing Europe 2012.
|<< || 1 2 3 4 || >>|
|Showing Results 11 - 20 of 40|